Upstream Bio (UPB) Accumulated Depreciation (2023 - 2026)

Upstream Bio's Accumulated Depreciation history runs 4 years deep, the most recent figure standing at $393000.0 for Q1 2026.

• In Q1 2026, Accumulated Depreciation rose 97.49% year-over-year to $393000.0; the TTM figure through Mar 2026 stood at $393000.0 (up 97.49% YoY), while the FY2025 annual figure was $344000.0, up 120.51% from the prior year.
• Accumulated Depreciation was $393000.0 for Q1 2026 at Upstream Bio, up from $344000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $393000.0 in Q1 2026 to a low of $67000.0 in Q4 2023.
• Historically, Accumulated Depreciation has averaged $224250.0 across 4 years, with a median of $220000.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Accumulated Depreciation jumped 168.22% in 2025, then surged 97.49% in 2026.
• A 4-year view of Accumulated Depreciation shows it stood at $67000.0 in 2023, then surged by 132.84% to $156000.0 in 2024, then surged by 120.51% to $344000.0 in 2025, then climbed by 14.24% to $393000.0 in 2026.
• The last three Accumulated Depreciation figures came in at $393000.0 (Q1 2026), $344000.0 (Q4 2025), and $287000.0 (Q3 2025), per Business Quant data.